CORPORATE OVERVIEW
Diabetes Sentry’s mission is to greatly improve the daily lives of Type-1 and Type-2 insulin dependent diabetics who suffer from a diabetes related chronic condition known as “hypoglycemia”. Leveraging 15 years of research and development the company’s patented and FDA approved medical device that targets this condition is ready for manufacturing and mass-market distribution. In addition to achieving regulatory clearances, the technology has been validated by the 1,500 customers already using the product who have provided many personal testimonials about its life changing and life saving benefits. Diabetes Sentry is not only an opportunity for the company and its investors to make money; it’s also an opportunity to make a significant difference in the world. Commercialization and scaling are the only steps that remain.